Electrophoretic analysis of PEGylated hemoglobin-based blood substitutes

Analytical Biochemistry

Volumn 408, Issue 1, 2011, Pages 118-123

  Ronda, Luca ^a   Pioselli, Barbara ^a   Bruno, Stefano ^a   Faggiano, Serena ^a   Mozzarelli, Andrea ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Blood substitutes; Electrophoresis; Hemoglobin; PEGylated proteins

Indexed keywords

BINDING ENERGY; BLOOD; BLOOD SUBSTITUTES; DRUG INTERACTIONS; ELECTROPHORESIS; PROTEINS;

DEGREE OF CONJUGATIONS; ELECTROPHORETIC ANALYSIS; HETEROGENEOUS PRODUCTS; PEGYLATED HEMOGLOBINS; PEGYLATED PROTEINS; PHARMACOKINETIC PROPERTIES; PROTEIN PEGYLATION; TWO-DIMENSIONAL POLYACRYLAMIDE GEL ELECTROPHORESIS;

HEMOGLOBIN;

BLOOD SUBSTITUTE; HEMOGLOBIN; MACROGOL; TETRAMER;

ARTICLE; ELECTROPHORESIS; MICROSPECTROPHOTOMETRY; MOLECULAR WEIGHT; OXYGEN AFFINITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 77958454555     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.08.043     Document Type: Article

References (22)

1. Leader B., Baca Q.J., Golan D.E. Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov. 2008, 7:21-39.
2. Stolnik S., Shakesheff K. Formulations for delivery of therapeutic proteins. Biotechnol. Lett. 2009, 31:1-11.
3. Mozzarelli A. Hemoglobin-based oxygen carriers as blood substitutes. Biochim. Biophys. Acta 2008, 1784:1363-1364.
4. Bjorkholm M., Fagrell B., Przybelski R., Winslow N., Young M., Winslow R.M. A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. Haematologica 2005, 90:505-515.
5. Olofsson C., Ahl T., Johansson T., Larsson S., Nellgard P., Ponzer S., Fagrell B., Przybelski R., Keipert P., Winslow N., Winslow R.M. A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified hemoglobin (Hemospan) in patients undergoing major orthopedic surgery. Anesthesiology 2006, 105:1153-1163.
6. Smani Y. Hemospan: a hemoglobin-based oxygen carrier for potential use as a blood substitute and for the potential treatment of critical limb ischemia. Curr. Opin. Invest. Drugs 2008, 9:1009-1019.
7. Portoro I., Kocsis L., Herman P., Caccia D., Perrella M., Ronda L., Bruno S., Bettati S., Micalella C., Mozzarelli A., Varga A., Vas M., Lowe K.C., Eke A. Towards a novel haemoglobin-based oxygen carrier: Euro-PEG-Hb, physico-chemical properties, vasoactivity, and renal filtration. Biochim. Biophys. Acta 2008, 1784:1402-1409.
8. Veronese F.M., Pasut G. PEGylation, successful approach to drug delivery. Drug Discov. Today 2005, 10:1451-1458.
9. Roberts M.J., Bentley M.D., Harris J.M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 2002, 54:459-476.
10. Li D., Manjula B.N., Acharya A.S. Extension arm facilitated PEGylation of hemoglobin: Correlation of the properties with the extent of PEGylation. Protein J. 2006, 25:263-274.
11. Manjula B.N., Tsai A.G., Intaglietta M., Tsai C.H., Ho C., Smith P.K., Perumalsamy K., Kanika N.D., Friedman J.M., Acharya S.A. Conjugation of multiple copies of polyethylene glycol to hemoglobin facilitated through thiolation: influence on hemoglobin structure and function. Protein J. 2005, 24:133-146.
12. Caccia D., Ronda L., Frassi R., Perrella M., Del Favero E., Bruno S., Pioselli B., Abbruzzetti S., Viappiani C., Mozzarelli A. PEGylation promotes hemoglobin tetramer dissociation. Bioconjug. Chem. 2009, 20:1356-1366.
13. Zheng C., Ma G., Su Z. Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation. Electrophoresis 2007, 28:2801-2807.
14. Hu T., Li D., Manjula B.N., Brenowitz M., Prabhakaran M., Acharya S.A. PEGylation of Val-1α destabilizes the tetrameric structure of hemoglobin. Biochemistry 2009, 48:608-616.
15. Li X.Z., Yang Q.H., Yan J.F., Xu K., Liu J., He X.Y., Zhang X.W., Liu Q. Characterization of poly(ethylene glycol)-modified bovine hemoglobin by capillary zone electrophoresis. Artif. Cells Blood Substit. Immobil. Biotechnol. 2007, 35:1-10.
16. Gonzalez L., Bustamante J.J., Barea-Rodriguez E.J., Martinez A.O., Haro L.S. 2-D native-PAGE/SDS-PAGE visualization of an oligomer's subunits: application to the analysis of IgG. Electrophoresis 2006, 27:2016-2023.
17. Ronda L., Bruno S., Faggiano S., Bettati S., Mozzarelli A. Oxygen binding to heme proteins in solution, encapsulated in silica gels, and in the crystalline state. Methods Enzymol. 2008, 437:311-328.
18. 6-Hb]. Artif. Cells Blood Substit. Immobil. Biotechnol. 2007, 35:19-29.
19. Iafelice R., Cristoni S., Caccia D., Russo R., Rossi-Bernardi L., Lowe K.C., Perrella M. Identification of the sites of deoxyhaemoglobin PEGylation. Biochem. J. 2007, 403:189-196.
20. Vandegriff K.D., Malavalli A., Wooldridge J., Lohman J., Winslow R.M. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 2003, 43:509-516.
21. Valdes R. Modification of human haemoglobin with glucose 6-phosphate enhances tetramer-dimer subunit dissociation. Biochem. J. 1986, 239:769-772.
22. Ananda K., Acharya S.A. Role of extension arm in PEG-Hb conjugates on the stability of the tetramer: non-conservative EAF maleimide thio-PEG mediated PEGylation. Artif. Cells Blood Substit. Immobil. Biotechnol. 2008, 36:499-512.